Known brain/leptomengial involvement of the disease, active neurological disease, dementia
History of seizure disorder, cerebrovascular ischemia/hemorrhage, dementia, cerebellar disease, or any autoimmune disease with CNS involvement
Neurological disorder (Parkinsons disease, dementia, multiple sclerosis)
History of HIV-associated encephalopathy; dementia of any kind; seizures in the past  months
Existing diagnosis of any type of dementia
History of significant neurologic or psychiatric disorders including dementia or seizures
Any history of HIV-associated encephalopathy; dementia of any kind; seizures in the past  months
Known brain/leptomengial involvement of the disease, active neurological disease, dementia
Other conditions which could jeopardize the subject's ability to comply with the protocol including but not limited to dementia, psychosis, or other major psychiatric disorder.
History of significant neurologic or psychiatric disorders, including dementia or seizures that would impede consent, treatment, or follow up
Serious or uncontrolled medical disorder (including infection or cardiovascular disease) or dementia or other serious psychiatric condition
History of a prior symptomatic stroke, dementia, or other significant central neurologic condition (i.e. multiple sclerosis)
Have dementia
Other medical or psychological conditions that would make participation unsafe or inhibit our ability to test our primary hypothesis, e.g. Parkinsons disease, severe dementia
Patients who are incompetent for interview (documented diagnosis of active psychosis or dementia) or unable to provide informed consent as assessed by the interviewer; or too sick to participate, as judged by a member of the research team or the exercise physiologist, or have been treated for another cancer
History of neurological disease (e.g., Parkinsons Disease, dementia, mild cognitive impairment)
Meet criteria for major neurological disorder, such as mild cognitive impairment or neurodegenerative disorders (such as movement disorders, dementia), that could be exacerbated by the administration of cannabis
Patients who are incompetent for interview (documented diagnosis of active psychosis or dementia) or unable to provide informed consent as assessed by the interviewer; or too sick to participate, as judged by a member of the research team
PATIENTS: History of Parkinsons disease or Alzheimers dementia
History of neurologic illness such as stroke, multiple sclerosis, multi-infarct dementia, or Parkinsons disease or history of dementia or chronic fatigue syndrome
Documented history of Alzheimers disease, dementia, or other neurologic deficit that could impact decision-making
Known or judged to be cognitively impaired (e.g., dementia, retardation, psychosis)
Have no documented or observable psychiatric or neurological disorders that would interfere with study participation (e.g., dementia, psychosis)
Have no documented or observable visual, auditory, psychiatric, or neurological disorders that would interfere with participation (e.g., blindness, deafness, psychosis, or dementia)
Have a history of dementia or major neurological illness
Dementia (i.e., .XX or .XX)
Individuals with pre-existing neurological disorder (i.e. brain tumors, dementia, Parkinsons disease, multiple sclerosis, seizure disorder) or diagnosed with metastasis cancer
Any past neurologic insult that is known to affect brain function such as traumatic brain injury, dementia, encephalopathy, etc.
History of Parkinsons disease or dementia
Medical or psychiatric conditions (beyond ovarian cancer, its treatment, and its symptoms) that would impair our ability to test study hypotheses (e.g. cardiac, pulmonary, or orthopedic history that would prohibit a program of walking for exercise; psychotic disorders, dementia, inability to give informed consent)
Diagnosis of dementia or unable to grant their own informed consent
Neurologic disorders of stroke, encephalitis, dementia, epilepsy, Alzheimers disease, Parkinsons disease
Participants must not have documented or observable visual, auditory, psychiatric, or neurological disorders that would interfere with study participation (e.g., blindness, deafness, psychosis, or dementia)
Any major thought disorder (e.g., schizophrenia, dementia)
Known history of cerebrovascular disease, dementia or prior non-mild traumatic brain injury
Neurologic disorders (dementia)
Diagnosis of dementia
Patients with impaired decision-making capacity (such as with a diagnosis of dementia or memory loss) are not eligible for this study
History of head injury or dementia.
PHASE I: Women who have dementia (of any kind) or memory problems listed in their problem list
PHASE I: Women that score >  on the Orientation-Memory-Concentration (OMC) test (indicative of dementia)
PHASE II: Women who have dementia (of any kind) or memory problems listed in their problem list and we will exclude women that score >  on the OMC test (indicative of dementia)
History of a seizure disorder, cerebrovascular ischemia/hemorrhage, dementia, cerebellar disease, or any autoimmune disease with CNS involvement